- 10.8.2024
- News
- Press Releases
Press Release: Veterans Exploring Treatment Solutions (VETS) Appoints James Carmichael as Chief Marketing Officer
Former NFL and Riot Games Executive Joins Non-Profit to Combat Veteran Suicide
- 9.25.2024
- News
Reason: Can This Psychedelic Help Cure Opioid Addiction?
As more states explore psychedelic-assisted therapy, Kentucky steps into the spotlight with ibogaine research. Advocates like Bryan Hubbard are paving the way for alternative treatments to address addiction and trauma. VETS stands with him.
- 9.24.2024
- News
Bizwomen | Dallas Business Journal: In Her Own Words: Amber Capone, veterans advocate
VETS CEO and cofounder, Amber Capone, shares her firsthand experience with the challenges that veterans, fueling her fierce advocacy for innovative healing solutions.
- 9.5.2024
- News
- Press Releases
Press Release: Veterans Exploring Treatment Solutions (VETS) Welcomes Two New Board Members
Dylan Hallerberg and Kevin Weiss Join VETS in its Mission to Empower Veterans and End the Veteran Suicide Epidemic
- 9.4.2024
- News
INDIEWIRE: ‘In Waves and War’ Review: A Moving Documentary About Wartime PTSD That Actually Offers Hope
Telluride: Jon Shenk and Bonni Cohen's second documentary at the Colorado festival in 2024 lets the personalities of its veterans shine.
- 9.4.2024
- News
VARIETY: ‘In Waves and War’ Review: Moving Doc About Afghanistan Vets Treating PTSD With Hallucinogens Is an Odyssey of the Mind
With animated sequences and intimate profiles, 'Athlete A' directors Jon Shenk and Bonni Cohen’s latest is another heartfelt look at a pressing social issue.
- 8.29.2024
- News
- Press Releases
Press Release: In Waves And War - Groundbreaking Documentary Featuring Veterans Seeking Healing - Set To Premiere At Telluride Film Festival
Veterans Exploring Treatment Solutions (VETS) Amber and Marcus Capone Featured as They Help Veterans Find Psychedelic-Assisted Therapy for PTSD and TBI
- 8.28.2024
- Blog
Navigating Complexity: Reflections on the FDA's MDMA-Assisted Therapy Decision and the Future of Psychedelic Medicine
The FDA’s recent decision to decline approval for MDMA-assisted therapy for PTSD, while disappointing, is not the end of the road. The agency’s request for further research serves as a reminder of the hurdles we still face in advancing psychedelic medicine through regulatory channels.
- 8.14.2024
- News
Microdose: FDA Rejected MDMA-Assisted PTSD Therapy: Psychedelic Industry Responds
Psychedelic industry leaders respond to the FDA's rejection of MDMA-assisted therapy for PTSD, emphasizing the ongoing fight for innovative mental health treatments and the need for new regulatory frameworks.
- 8.10.2024
- News
VETS Stands Firm: Our Response to the FDA's Decision on MDMA-Assisted Therapy
Today, the Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Lykos Therapeutics in response to their application for approval of MDMA-assisted therapy.